๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Screening for carcinoma of the prostate

โœ Scribed by Alexander, Freda E.


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
25 KB
Volume
32
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Screening for carcinoma of the prostate
โœ Pirkko Vihko; Matti Kontturi; Olavi Lukkarinen; Juha Ervasti; Reijo Vihko ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 416 KB ๐Ÿ‘ 1 views

Veterans (n = 771, 54-76 years of age) from the Second World War, who attended a rehabilitation program arranged by the state between the years 1979 and 1983, were screened for prostatic cancer by rectal examination of the prostate and by measurement of serum prostate-specific acid phosphatase (PAP)

Screening for prostate cancer
โœ Michael K. Brawer ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 51 KB ๐Ÿ‘ 1 views

Screening for prostate cancer has shown great promise in its ability to detect prostate cancer at a curable stage; however, significant problems exist with respect to our knowledge of its impact on prostate cancer mortality. For the properly informed patient with at least a 10year life expectancy, i

Screening for prostate cancer
โœ Sam D. Graham Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 255 KB ๐Ÿ‘ 2 views
Quality-of-life outcomes for men with pr
โœ Deborah S. Smith; Gustavo F. Carvalhal; Kay Schneider; Julie Krygiel; Yan Yan; W ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 1 views

## BACKGROUND. There is limited information on outcomes of prostate carcinoma treatments given to screened patient populations for whom cancer is usually detected at an earlier stage. ## METHODS. The authors conducted a cross-sectional evaluation of quality-of-life outcomes for men with prostate

Future benefits and cost-effectiveness o
โœ Peter J. Littrup ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 2 views

Estimates of cost-effectiveness for prostate carcinoma screening require a review of current data, modeling efforts, and perspectives on societal impact and costs. ## METHODS. Recent data from the cancer registry of the Michigan Department of Community Health was assessed for incidence trends in r